Mini DuoCol® 2% Solution: Fermentation-Derived Collagen, Bioengineered for Deep Skin Delivery
Mini DuoCol® 2% Solution was developed by Trautec, a U.S. biotech innovator holding exclusive IP in recombinant collagen, in collaboration with the DKSH North America Innovation Center. Their breakthrough wasn’t just producing collagen through fermentation, it was making it scalable, high-purity, and fully compatible with human skin. Today, DKSH brings this breakthrough to market with exclusive global distribution of Mini DuoCol® 2% Solution.